FundedIQ
Biotechnology

Karuna Therapeutics: Funding, Investors & Team (Aug 2026)

Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions.

karunatx.com LinkedIn Boston, United States 101-250 employees
Total raised
$750M
Rounds
1
Latest
Post-IPO Equity
Aug 2022

Karuna Therapeutics has raised $750M across 1 funding round on record, the most recent a Post-IPO Equity of $750M announced in Aug 2022.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Karuna Therapeutics Company Profile and Key Stats

Total funding raised
$750M
across 1 round on record
Funding rounds on record
1
Latest funding round
Post-IPO Equity
$750M in Aug 2022
Employees
101-250
reported band
Headquarters
Boston, United States

Latest funding round on record: Aug 2022.

Karuna Therapeutics Funding Rounds

Date
Round
Amount
Post-IPO Equity
$750M

Karuna Therapeutics Founders and Leadership Team

Name
Role
Contact
Andrew Miller
Founder
Locked

Contact details for the Karuna Therapeutics team: 1 of 1 has an email address on file.

Start 14-day free trial →

Karuna Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round

Karuna Therapeutics' latest round of $750M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Karuna Therapeutics in Biotechnology and Boston

Companies Similar to Karuna Therapeutics

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Karuna Therapeutics Funding FAQs

What does Karuna Therapeutics do?

Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions.

How much funding has Karuna Therapeutics raised?

Karuna Therapeutics has raised $750M across 1 round on record. The most recent is a Post-IPO Equity of $750M announced in Aug 2022.

When did Karuna Therapeutics last raise funding?

Karuna Therapeutics' most recent funding round on record is a Post-IPO Equity of $750M, announced in Aug 2022.

Who founded Karuna Therapeutics?

FundedIQ lists Andrew Miller (Founder) at Karuna Therapeutics.

Where is Karuna Therapeutics headquartered?

Karuna Therapeutics is based in Boston, Massachusetts, United States.

How many employees does Karuna Therapeutics have?

Karuna Therapeutics is in the 101-250 employee band.

How does Karuna Therapeutics' funding compare to other Biotechnology startups?

Karuna Therapeutics' latest round of $750M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Karuna Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Karuna Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.